Antonio R. Cabral

2.5k total citations
53 papers, 1.6k citations indexed

About

Antonio R. Cabral is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging and Hematology. According to data from OpenAlex, Antonio R. Cabral has authored 53 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Rheumatology, 18 papers in Radiology, Nuclear Medicine and Imaging and 16 papers in Hematology. Recurrent topics in Antonio R. Cabral's work include Systemic Lupus Erythematosus Research (33 papers), Monoclonal and Polyclonal Antibodies Research (18 papers) and Platelet Disorders and Treatments (14 papers). Antonio R. Cabral is often cited by papers focused on Systemic Lupus Erythematosus Research (33 papers), Monoclonal and Polyclonal Antibodies Research (18 papers) and Platelet Disorders and Treatments (14 papers). Antonio R. Cabral collaborates with scholars based in Mexico, Canada and United States. Antonio R. Cabral's co-authors include D Alarcón-Segovia, Javier Cabiedes, Janette Furuzawa‐Carballeda, María Inés Vargas-Rojas, Diego F. Hernández‐Ramírez, Carlos A. Núñez‐Álvarez, Gabriela Hernández‐Molina, Jason S. Knight, Paula Bockenstedt and Srilakshmi Yalavarthi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Biochemical and Biophysical Research Communications.

In The Last Decade

Antonio R. Cabral

50 papers receiving 1.6k citations

Peers

Countries citing papers authored by Antonio R. Cabral

Since Specialization

Citations

This map shows the geographic impact of Antonio R. Cabral's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio R. Cabral with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio R. Cabral more than expected).

Fields of papers citing papers by Antonio R. Cabral

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio R. Cabral. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio R. Cabral. The network helps show where Antonio R. Cabral may publish in the future.

Co-authorship network of co-authors of Antonio R. Cabral

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio R. Cabral. A scholar is included among the top collaborators of Antonio R. Cabral based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio R. Cabral. Antonio R. Cabral is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Delegação de competências no processo estrutural 2024 ·SHILAP Revista de lepidopterología ·Antonio R. Cabral	0
2	Prediction of Response to Treatment Using Doppler Signal Positivity Measured by Ultrasound in Rheumatoid Arthritis: A Proof-of-Concept Study 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Dilek Solmaz, Nancy Maltez, (unknown), Antonio R. Cabral, Servet Akar, Sibel Zehra Aydın, (unknown)	2
3	Prevalence and associations of anti-phosphatidylserine/prothrombin antibodies with clinical phenotypes in patients with primary antiphospholipid syndrome 2018 ·Thrombosis Research ·Carlos A. Núñez‐Álvarez, Gabriela Hernández‐Molina, (unknown), (unknown), Diego F. Hernández‐Ramírez, (unknown), Antonio R. Cabral	19
4	Cellular immune response to β2-glycoprotein-I valine/leucine247 phenotypes in Mexican patients with primary antiphospholipid syndrome 2016 ·Human Immunology ·Carlos A. Núñez‐Álvarez, Diego F. Hernández‐Ramírez, (unknown), (unknown), Javier Cabiedes, Alicia Ortega, Antonio R. Cabral	1
5	Endothelial progenitor dysfunction associates with a type I interferon signature in primary antiphospholipid syndrome 2016 ·Annals of the Rheumatic Diseases ·(unknown), Srilakshmi Yalavarthi, Alex A. Gandhi, (unknown), Carlos A. Núñez‐Álvarez, Diego F. Hernández‐Ramírez, Antonio R. Cabral, W. Joseph McCune, Paula Bockenstedt, Jason S. Knight	55
6	The amount of citrullinated proteins in synovial tissue is related to serum anti-cyclic citrullinated peptide (anti-CCP) antibody levels 2015 ·Clinical Rheumatology ·(unknown), Diego F. Hernández‐Ramírez, Carlos A. Núñez‐Álvarez, Antonio R. Cabral, Luis Llorente	4
7	The role of β2-glycoprotein I (β2GPI) carbohydrate chains in the reactivity of anti-β2GPI antibodies from patients with primary antiphospholipid syndrome and in the activation and differentiation of U937 cells 2014 ·Biochemical and Biophysical Research Communications ·Diego F. Hernández‐Ramírez, (unknown), Carlos A. Núñez‐Álvarez, (unknown), Enrique García‐Hernández, (unknown), Luis Llorente, Antonio R. Cabral	4
8	Anti-β2GP-I and Anti-Prothrombin Antibodies Generated by Phage Display 2009 ·Methods in molecular biology ·Javier Cabiedes, Antonio R. Cabral	1
9	Autoimmune inflammation from the Th17 perspective 2006 ·Autoimmunity Reviews ·Janette Furuzawa‐Carballeda, María Inés Vargas-Rojas, Antonio R. Cabral	231
10	Characterization of monoclonal anti-β2-glycoprotein-I and anti-prothrombin antibody fragments generated by phage display from a patient with primary antiphospholipid syndrome 2005 ·Journal of Autoimmunity ·(unknown), Baltazar Becerril, Antonio R. Cabral, (unknown), Virginia Pascual, Diego F. Hernández‐Ramírez, Javier Cabiedes	14
11	Subcutaneous administration of polymerized-type I collagen for the treatment of patients with rheumatoid arthritis. An open-label pilot trial. 2003 ·PubMed ·Janette Furuzawa‐Carballeda, Antonio R. Cabral, (unknown), Jorge Alcocer‐Varela	15
12	Antiprothrombin Antibodies in Patients With Systemic Lupus Erythematosus or With Primary Antiphospholipid Syndrome 2002 ·JCR Journal of Clinical Rheumatology ·Francisco Salcido-Ochoa, Javier Cabiedes, D Alarcón-Segovia, Antonio R. Cabral	12
13	The anti-phospholipid antibody syndrome: clinical and serological aspects 2000 ·Best Practice & Research Clinical Rheumatology ·D Alarcón-Segovia, Antonio R. Cabral	5
14	Serum anti-β2-glycoprotein-I and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients 1999 ·The American Journal of Medicine ·(unknown), Antonio Villa, Cristina Drenkard, Javier Cabiedes, Antonio R. Cabral, D Alarcón-Segovia	55
15	Etica y medicina 1998 ·Revista de la Universidad de México ·Antonio R. Cabral	2
16	Hidden anti-phospholipid antibodies in normal human sera circulate as immune complexes whose antigen can be removed by heat, acid, hypermolar buffers or phospholipase treatments 1998 ·European Journal of Immunology ·Javier Cabiedes, Antonio R. Cabral, D Alarcón-Segovia	36
17	Tween 20 detaches cardiolipin from ELISA plates and makes anticardiolipin antibodies undetectable regardless of the presence of β2-glycoprotein-I 1994 ·Journal of Immunological Methods ·Antonio R. Cabral, Javier Cabiedes, Donato Alarcón-Segovia	17
18	Phospholipid specificity and requirement of β2-glycoprotein-I for reactivity of antibodies from patients with primary antiphospholipid syndrome 1992 ·Journal of Autoimmunity ·Antonio R. Cabral, Javier Cabiedes, D Alarcón-Segovia, Jorge Sánchez‐Guerrero	27
19	Decrease in serum antiphospholipid antibody levels upon development of nephrotic syndrome in patients with systemic lupus erythematosus: Relationship to urinary loss of IgG and other factors 1992 ·The American Journal of Medicine ·(unknown), Javier Cabiedes, Antonio R. Cabral, D Alarcón-Segovia	23
20	Connective tissue activation. xxxi. identification of two molecular forms of a human mesenchymal cell—derived growth factor, connective tissue activating peptide—V 1987 ·Arthritis & Rheumatism ·Antonio R. Cabral, C. William Castor	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact